Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

417

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia, Myelomonocytic, Chronic

Interventions

DRUG: Guadecitabine
OTHER: Treatment Choice

Sponsor

Astex Pharmaceuticals, Inc.